SEK 0.14
(0.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.08 SEK | 74.3% |
2022 | -0.33 SEK | 38.89% |
2021 | -0.54 SEK | 10.0% |
2020 | -0.60 SEK | 17.81% |
2019 | -0.73 SEK | 29.81% |
2018 | -1.04 SEK | 76.68% |
2017 | -4.46 SEK | -479.22% |
2016 | -0.77 SEK | -527.78% |
2015 | 0.18 SEK | 263.64% |
2014 | -0.11 SEK | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | -0.03 SEK | -13.73% |
2024 Q2 | -0.02 SEK | 31.61% |
2023 Q4 | -0.03 SEK | -20.47% |
2023 FY | - SEK | 60.61% |
2023 Q1 | -0.06 SEK | 37.35% |
2023 Q2 | -0.06 SEK | 7.85% |
2023 Q3 | -0.03 SEK | 55.83% |
2022 Q4 | -0.10 SEK | -29.69% |
2022 FY | - SEK | 38.89% |
2022 Q2 | -0.09 SEK | 19.27% |
2022 Q1 | -0.11 SEK | 21.43% |
2022 Q3 | -0.08 SEK | 13.51% |
2021 Q3 | -0.15 SEK | -52.59% |
2021 FY | - SEK | 10.0% |
2021 Q1 | -0.12 SEK | -20.36% |
2021 Q2 | -0.10 SEK | 18.08% |
2021 Q4 | -0.14 SEK | 6.67% |
2020 Q4 | -0.10 SEK | 23.31% |
2020 FY | - SEK | 17.81% |
2020 Q3 | -0.13 SEK | 48.0% |
2020 Q1 | -0.19 SEK | 13.64% |
2020 Q2 | -0.25 SEK | -31.58% |
2019 FY | - SEK | 29.81% |
2019 Q4 | -0.22 SEK | -29.41% |
2019 Q3 | -0.17 SEK | 26.09% |
2019 Q2 | -0.23 SEK | -43.75% |
2019 Q1 | -0.16 SEK | 15.79% |
2018 FY | - SEK | 76.68% |
2018 Q1 | -1.02 SEK | 20.93% |
2018 Q2 | -0.81 SEK | 20.59% |
2018 Q3 | -0.76 SEK | 6.17% |
2018 Q4 | -0.19 SEK | 75.0% |
2017 Q2 | -1.11 SEK | -58.57% |
2017 Q3 | -1.19 SEK | -7.21% |
2017 Q4 | -1.29 SEK | -8.4% |
2017 FY | - SEK | -479.22% |
2017 Q1 | -0.70 SEK | -29.63% |
2016 Q4 | -0.54 SEK | 0.0% |
2016 FY | - SEK | -527.78% |
2015 FY | - SEK | 263.64% |
2014 FY | - SEK | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Bonzun AB (publ) | 0.11 SEK | 177.091% |
Kontigo Care AB (publ) | 0.01 SEK | 1063.636% |
Medhelp Care Aktiebolag (publ) | -0.36 SEK | 76.444% |
RaySearch Laboratories AB (publ) | 2.38 SEK | 103.563% |
Surgical Science Sweden AB (publ) | 4.59 SEK | 101.847% |